TOP NEWS: AstraZeneca's Virus Antibody Trials Move To Phase III Read More
UK BROKER RATINGS SUMMARY: JPMorgan Upgrades Network International Read More
TOP NEWS: AstraZeneca Resumes Covid-19 Vaccine AZD1222 Trial In Japan Read More
LONDON MARKET PRE-OPEN: AstraZeneca's Farxiga Gets US Breakthrough Tag Read More
Breakthrough Therapy Designation For Astra's Farixga In Kidney Disease Read More
AstraZeneca Virus Vaccine In Rolling Review By European Regulator Read More
UK BROKER RATINGS SUMMARY: Berenberg Says Buy AstraZeneca And Glaxo Read More
AstraZeneca Appoints Stanford University Professor Ashley To Board Read More
UK BROKER RATINGS SUMMARY: ODDO BHF Upgrades Astra And Glaxo Read More
PRESS: Scientists Demand Clarity Over Astra's Covid-19 Vaccine Trial Read More
TOP NEWS: Astra's Lynparza Gets EU Ok For Ovarian And Prostate Cancer Read More
LONDON MARKET PRE-OPEN: Lower Start Seen; Informa Posts Interim Loss Read More
TOP NEWS: Positive Results For AstraZeneca Drugs Imfinzi And Lynparza Read More
Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal Read More
Silence Therapeutics Appoints Mark Rothera As CEO; Annual Loss Widens Read More
LONDON MARKET MIDDAY: FTSE Dips As Early Boost From Vaccine News Fades Read More
LONDON MARKET OPEN: Bumper M&A Deals And Vaccine Hopes Lift Stocks Read More
AstraZeneca, Oxford University Resume Covid-19 Vaccine Trials In UK Read More
Astra Says Vaccine Still Possible This Year Despite Trial Pause Read More
TOP NEWS: Vaccine Still Possible Despite Trial Halt - AstraZeneca Read More
